VISUfarma is pan-European ophthalmic specialty pharmaceutical company with a clear mission; to bring global innovation to European eye health. It is an ambitious and fast growing ophthalmology player, commercialising a wide portfolio of products and devices across Europe. VISUfarma’s promise is to offer high quality products and to spread eye health innovation and knowledge, from across the globe, throughout Europe. The VISUfarma platform is underpinned by the acquisition of the international commercial operations of Nicox SA (France) and Visufarma SpA (Italy) and will be further enhanced through strategic partnerships with global partners. VISUfarma fosters a unique network in the ophthalmology space which enables physicians, hospitals and medical centres to provide patients with the highest quality eye care. The Company was founded in 2016 and has a strong presence in five European countries: France, Germany, Italy, Spain and the United Kingdom. The company has more than 150 employees and its head office is based in Amsterdam, the Netherlands.
all, PharmaBio, Current
Investment date
July 2016
Deal status
Our portfolio